Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kristine,Ashcraft

第一单位： Invitae Corporation, San Francisco, CA 94103, USA.

作者： Kristine,Ashcraft ^[1] ; Chad,Moretz ^[1] ; Chantelle,Schenning ^[1] ; Susan,Rojahn ^[1] ; Kae,Vines Tanudtanud ^[2] ; Gwyn Omar,Magoncia ^[2] ; Justine,Reyes ^[2] ; Bernardo,Marquez ^[2] ; Yinglong,Guo ^[2] ; Elif Tokar,Erdemir ^[2] ; Taryn O,Hall ^[2]

作者单位： Invitae Corporation, San Francisco, CA 94103, USA. ^[1] OptumLabs at UnitedHealth Group, Minnetonka, MN 55343, USA. ^[2]

关键词 COVID-19 healthcare administration healthcare costs hierarchical conditions category (HCC)hospitalization length of stay medication management pharmacogenomics precision medicine risk adjustment factor (RAF)

DOI 10.3390/jpm11111192

PMID 34834543

发布时间 2021-11-30

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of personalized medicine

2021年11卷11期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study.

Journal of personalized medicine

相似文献

Journal of personalized medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Unmanaged Pharmacogenomic and Drug Interaction Risk Associations with Hospital Length of Stay among Medicare Advantage Members with COVID-19: A Retrospective Cohort Study.

Journal of personalized medicine

相似文献

Journal of personalized medicine

相关期刊

检索历史清除